ALS-associated RNA-binding proteins promote UNC13A transcription through REST downregulation - (https://www.embopress.org/doi ...

Matteo Materazzi's battle against a rare form of ALS has prompted his wife to launch a fundraiser to fund personalized ...

Neuvivo and the FDA have agreed on a regulatory pathway for NP001 (sodium chlorite) to treat ALS, with Phase 3 testing ...

Neurodegenerative diseases are surging, yet our nation slumbers, unaware of the devastation ahead. This illusion of rarity perpetuates a deadly inaction that extends to all brain diseases. Alzheimer's ...

Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its ...

In ALS, the loss of certain proteins turns off a gene called UNC13A that needs to stay active for nerve cell communication, a ...

A recent study has revealed a critical gap in the use of accessibility features among people living with Amyotrophic Lateral ...

Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

The Boxing Event brings fighters from across Texas to the ring — all to raise money for gym, nonprofits and raise awareness ...

The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...

Researchers from Biotiche Drug Discovery Srl and collaborators have discovered that modulating the activity of a specific ...

Neuralink is crossing the pond. Elon Musk’s brain chip is due to start clinical trials in Great Britain, and he is inviting ...